Pulmatrix (PULM) Stock Chart & Stock Price History $4.77 +0.30 (+6.62%) As of 08/22/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Pulmatrix Stock Price Performance The Pulmatrix (PULM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 144.50%, with a year-to-date return of -29.94%. In the past month, the stock has decreased 12.83%, reflecting recent market activity. As of the latest close, Pulmatrix traded at $4.89 with a market cap of and volume of 14,341 shares. Five years ago, the stock traded at a split-adjusted price of $23.60, representing a 79.28% decrease over that period. At the time, it had a market cap of and a volume of 517,324 shares. Receive PULM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pulmatrix and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+5.84%1 Month Performance-12.83%3 Month Performance-28.19%Year-To-Date Performance-29.94%1 Year Performance+144.50%5 Year Performance-79.28% PULM Stock Chart for Sunday, August, 24, 2025 PULM Chart by TradingView Pulmatrix Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/22/2025$4.47$4.89+9.40%$4.89$4.4514,341 shs$17.85 million08/21/2025$4.53$4.47-1.32%$4.54$4.4625,728 shs$0.0008/20/2025$4.62$4.53-1.95%$4.75$4.4419,639 shs$0.0008/19/2025$4.71$4.62-1.91%$4.85$4.626,630 shs$16.86 million08/18/2025$4.71$4.71$4.90$4.6711,029 shs$0.0008/15/2025$5.02$4.71-6.18%$5.00$4.7014,000 shs$0.0008/14/2025$4.65$5.02+7.96%$5.09$4.704,602 shs$0.0008/13/2025$5.00$4.65-7.00%$5.00$4.6524,848 shs$16.97 million08/12/2025$5.00$5.00$5.25$4.963,221 shs$0.0008/11/2025$5.07$5.00-1.38%$5.14$5.004,220 shs$0.00 Get the Latest News and Ratings for PULM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pulmatrix and its competitors with MarketBeat's FREE daily newsletter. 08/08/2025$5.27$5.07-3.80%$5.44$4.9124,804 shs$0.0008/07/2025$5.37$5.27-1.86%$5.40$5.1410,209 shs$0.0008/06/2025$5.48$5.37-2.01%$5.45$5.3112,356 shs$20.00 million08/05/2025$5.45$5.48+0.64%$5.58$5.228,588 shs$0.0008/04/2025$5.33$5.45+2.16%$5.50$5.388,441 shs$0.0008/01/2025$5.63$5.33-5.33%$5.55$5.335,998 shs$0.0007/31/2025$5.57$5.63+1.08%$5.76$5.413,288 shs$20.55 million07/30/2025$5.30$5.57+5.17%$5.61$5.297,874 shs$0.0007/29/2025$5.26$5.30+0.68%$5.39$5.207,290 shs$0.0007/28/2025$5.62$5.26-6.41%$5.80$5.2214,375 shs$19.20 million07/25/2025$5.61$5.62+0.18%$5.80$5.616,560 shs$20.51 million07/24/2025$6.02$5.61-6.81%$6.15$5.6022,652 shs$0.0007/23/2025$6.08$6.02-0.99%$6.12$6.0110,380 shs$0.00 Related Companies OS Therapies Stock Price Chart Immix Biopharma Stock Price Chart Ovid Therapeutics Stock Price Chart INmune Bio Stock Price Chart Genenta Science Stock Price Chart Repare Therapeutics Stock Price Chart Adlai Nortye Stock Price Chart MediciNova Stock Price Chart Gain Therapeutics Stock Price Chart Cue Biopharma Stock Price Chart Receive PULM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pulmatrix and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PULM) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe Secret E.I. Project No One’s Talking About… YetIt took Netflix 3.5 years to reach 1 million users. Twitter? Two years. Facebook? Ten months. ChatGPT? Just 5 ...Behind the Markets | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulmatrix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulmatrix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access